Human Chorionic Gonadotropin Test Market Analysis

The human chorionic gonadotropin (HCG) market is segmented based on technology into natural source extraction, and recombinant technology, out of which, natural source extraction segment is anticipated to grab the largest share by the end of 2021 on account of increased number investments by the major players to extract gonadotropins from natural source. However, increasing government approval of digital devices globally is also projected to contribute to the growth of the recombinant technology segment is expected to increase with a rapid growth rate on the back of increasing availability of recombinant hCGs during the forecast period.

Based on therapeutic area, the female infertility segment held the largest share in the global Human chorionic gonadotropin (HCG) market on the back of growing concern and awareness for infertility among the couples and individuals across the developing and under-developed countries.

Our in-depth analysis of the global market includes the following segments

By Technology

Natural Source Extraction
Recombinant Technology

By Therapeutic Area

Female Infertility Treatment
Male Hypogonadism
Oligospermic Treatment
Others

By End-User

Fertility Clinics
Research Institutes
Others

Frequently Asked Questions (FAQ)

Rising cases of infertility and increasing in the incidence of male hypogonadism are the key factors driving market growth.

The market is anticipated to attain a high CAGR over the forecast period, i.e., 2021-2029.

With respect to therapeutic area, the female infertility segment is anticipated to hold the largest market share owing to the growing number of infertility cases among the young women.

The market in Asia Pacific region will provide ample growth opportunities owing to the increasing population and infertility among individuals.

The major players dominating the Human Chorionic Gonadotropin (hCG) Test market are Merck & Co., Cigna, Lee BioSolutions, Swiss Precision Diagnostics GmbH, Abbott Laboratories, Quidel Corporation, Geratherm Medical AG, bioMÃ©rieux SA, CIGA Healthcare Ltd, and Others.

Human Chorionic Gonadotropin Test Market Analysis